ストックスクリーナーアプリを入手
0.242
4.04%
-0.0102
アフターアワーズ：
.25
0.008
+3.31%
Azitra Inc (AZTR) 最新ニュース
Azitra, Inc. to Present at The Microcap Conference - Citizentribune
Azitra CEO to Present at Microcap Conference 2025, Showcase Clinical Pipeline - StockTitan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Azitra stock plunges to 52-week low at $0.24 amid steep decline - Investing.com
Branford biopharma firm Azitra prices $1.5M public stock offering - Hartford Business Journal
Azitra announces pricing of $1.5M public offering of common stock - MSN
SEC Form 424B5 filed by Azitra Inc - Quantisnow
Dow Jumps 600 Points; US Inflation Increases To 2.9% In December - Benzinga
Azitra sets price for $1.5 million stock offering - Investing.com
Azitra Announces Pricing of $1.5 Million Public Offering of Common Stock - Nasdaq
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Why Vision Marine Technologies Shares Are Trading Higher By 68%; Here Are 20 Stocks Moving Premarket - Benzinga
Azitra launches public stock offering By Investing.com - Investing.com Australia
SEC Form 424B3 filed by Azitra Inc - Quantisnow
Azitra launches public stock offering - Investing.com
Azitra Announces Common Stock Public Offering with Maxim Group as Placement Agent - StockTitan
Azitra stock plunges to 52-week low of $0.38 amid steep decline By Investing.com - Investing.com South Africa
Azitra stock plunges to 52-week low of $0.38 amid steep decline - Investing.com Nigeria
Azitra (NYSEAMERICAN:AZTR) Trading 14% Higher – Should You Buy? - Defense World
Azitra, Inc. to Present at Biotech Showcase 2025 alongside the J.P. Morgan Annual Healthcare Conference - Marketscreener.com
Azitra, Inc. to Present at Biotech Showcase 2025 Alongside the J.P. Morgan Annual Healthcare Conference - StreetInsider.com
Azitra to Present Growth Strategy at Biotech Showcase 2025: Clinical Pipeline & Development Plans in Focus - StockTitan
Azitra stock plunges to 52-week low, hits $0.42 - Investing.com India
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Bu - GuruFocus.com
AZTR: Planning 2nd Site for ATR-12 Trial - MSN
Azitra stock plunges to 52-week low at $0.46 amid steep decline - Investing.com Australia
500: Something went wrong - Investing.com Canada
Azitra (NYSEAMERICAN:AZTR) Shares Down 3.9% – Here’s Why - Defense World
Azitra, Inc. Announces Q3 2024 Financial Results and Provides Business Updates - PR Newswire
Azitra Q3: FDA Fast Track Win Despite Revenue Drop; $10M Offering Bolsters Pipeline - StockTitan
Azitra to Present at BIO-Europe 2024 - BioSpace
Azitra to Participate in the 2024 Maxim Healthcare Virtual Summit - Marketscreener.com
Azitra Joins 2024 Maxim Healthcare Virtual Summit - FinancialNews.co.uk
Netherton Syndrome Treatment Industry is Expected to Reach $8 Billion by 2034 -Lifemax Laboratories, Azitra, Inc, Sixera – IndiaPolitics.com - IndiaPolitics.com
Azitra stock plunges to 52-week low, hits $0.49 By Investing.com - Investing.com South Africa
Azitra stock plunges to 52-week low, hits $0.49 - Investing.com
Anitra (AMEX:AZTR) Stock Quotes, Forecast and News Summary - Benzinga
Azitra to present EGFR inhibitor toxicity treatment data By Investing.com - Investing.com Australia
Azitra to present EGFR inhibitor toxicity treatment data - Investing.com India
AZTRAzitra Inc Latest Stock News & Market Updates - StockTitan
Mexico's inflation undershoots forecasts ahead of rate decision - Investing.com
Azitra, Inc. Announces Late-Breaking Presentation at the European Academy of Dermatology and Venereology Congress - Business Wire
AZTR’s Market Fluctuations: Is Now the Right Time to Invest? - The InvestChronicle
3.95%
2.39%
大文字化:
|
ボリューム (24 時間):